Skip to content

In Vitro and In Vivo Comparison Between Intravascular Ultrasound (IVUS) Systems

Simultaneous Acquisition of Intravascular Ultrasound and Near Infrared Spectroscopy Data in the Coronary Artery Study

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02154295
Acronym
SAVOIR2
Enrollment
16
Registered
2014-06-03
Start date
2014-05-31
Completion date
2014-08-31
Last updated
2020-12-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary Artery Disease

Brief summary

The purpose of this study is to investigate and compare the images obtained from coronary imaging catheters used in the treatment of coronary blockages both in a clinical setting with patients and in models.

Interventions

DEVICEInfraredx Test Catheter

Sponsors

South Australian Health and Medical Research Institute
CollaboratorOTHER
Royal Adelaide Hospital
CollaboratorOTHER
Infraredx
Lead SponsorINDUSTRY

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SCREENING
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* ≥18 years of age * Scheduled for a coronary angiogram at the Royal Adelaide Hospital. * Women must be non-lactating or not of childbearing potential (1 year post menopausal or surgically sterilized \[total hysterectomy, bilateral tubal ligation, bilateral oophorectomy\]). * Target artery must be \>2 mm to accommodate the IVUS catheter. * IVUS must be clinically indicated or indeterminate angiographic lesion in the artery (40%-70% angiographic stenosis)

Exclusion criteria

* Cardiogenic shock * Contraindications to intracoronary nitroglycerin (hypertrophic obstructive cardiomyopathy; cerebral hemorrhage, head trauma; concomitant sildenafil, tadalafil or vardenafil use) * Known coronary artery spasm * Significant bleeding risk (i.e. previous hemorrhagic stroke, active peptic ulcer disease) * Bleeding diathesis * Significant renal impairment (patients will be excluded if their calculated creatinine clearance is \< 30 mL/min)

Design outcomes

Primary

MeasureTime frame
Clarity of Image and ease of interpretation as measured by physician surveyDay 0

Secondary

MeasureTime frame
Comparison of diameters and areas using ultrasound imaging from a standard test fixture(model) and test cathetersDay 0

Countries

Australia

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026